South & Central America Transdermal Drug Delivery System Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Type (Transdermal Patches, Transdermal Gel, Transdermal Sprays, and Others), Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications, and Other Applications), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

No. of Pages: 94
Report Code: BMIRE00030134
Category: Life Sciences
South & Central America Transdermal Drug Delivery System Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South & Central America Transdermal Drug Delivery System Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South & Central America Transdermal Drug Delivery System Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South & Central America Transdermal Drug Delivery System Market Regional Analysis

6.2 South & Central America Transdermal Drug Delivery System Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Transdermal Drug Delivery System Market Forecast Analysis

7. South & Central America Transdermal Drug Delivery System Market Analysis – by Type

7.1 Transdermal Patches
  • 7.1.1 Overview
  • 7.1.2 Transdermal Patches: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Transdermal Gel
  • 7.2.1 Overview
  • 7.2.2 Transdermal Gel: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Transdermal Sprays
  • 7.3.1 Overview
  • 7.3.2 Transdermal Sprays: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. South & Central America Transdermal Drug Delivery System Market Analysis – by Application

8.1 Cardiovascular Diseases
  • 8.1.1 Overview
  • 8.1.2 Cardiovascular Diseases: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Central Nervous System Disorders
  • 8.2.1 Overview
  • 8.2.2 Central Nervous System Disorders: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Pain Management
  • 8.3.1 Overview
  • 8.3.2 Pain Management: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Hormonal Applications
  • 8.4.1 Overview
  • 8.4.2 Hormonal Applications: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Other Applications
  • 8.5.1 Overview
  • 8.5.2 Other Applications: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. South & Central America Transdermal Drug Delivery System Market Analysis – by Distribution Channel

9.1 Hospitals Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Hospitals Pharmacies: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Retail Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Retail Pharmacies: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Online Pharmacies
  • 9.3.1 Overview
  • 9.3.2 Online Pharmacies: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. South & Central America Transdermal Drug Delivery System Market – South and Central America Analysis

10.1 Overview

10.2 South and Central America
  • 10.2.1 South & Central America Transdermal Drug Delivery System Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.2.1.1 South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Brazil: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.1.1 Brazil: South & Central America Transdermal Drug Delivery System Market Breakdown, by Type
    • 10.2.1.1.2 Brazil: South & Central America Transdermal Drug Delivery System Market Breakdown, by Application
    • 10.2.1.1.3 Brazil: South & Central America Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
  • 10.2.1.2 Argentina: South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.2.1 Argentina: South & Central America Transdermal Drug Delivery System Market Breakdown, by Type
    • 10.2.1.2.2 Argentina: South & Central America Transdermal Drug Delivery System Market Breakdown, by Application
    • 10.2.1.2.3 Argentina: South & Central America Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
  • 10.2.1.3 Rest of South and Central America : South & Central America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.2.1.3.1 Rest of South and Central America : South & Central America Transdermal Drug Delivery System Market Breakdown, by Type
    • 10.2.1.3.2 Rest of South and Central America : South & Central America Transdermal Drug Delivery System Market Breakdown, by Application
    • 10.2.1.3.3 Rest of South and Central America : South & Central America Transdermal Drug Delivery System Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Boehringer Ingelheim International GmbH
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 GSK Plc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Hisamitsu Pharmaceutical Co Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Johnson & Johnson
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Novartis AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Viatris Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - South & Central America Transdermal Drug Delivery System Market

  • Boehringer Ingelheim International GmbH
  • GSK Plc
  • Hisamitsu Pharmaceutical Co Inc
  • Johnson & Johnson
  • Novartis AG
  • Viatris Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)